COVID-19 Resources

See how COVID-19 affects kidney health, receive guidance on how to clean our products and our response to the pandemic.

Upcoming Events

Join ACIST for upcoming events.

 

 

Why ACIST?

ACIST Medical Systems provides diagnostic technologies that deliver the power to visualize, assess and improve patient treatment. 

Your cath lab knowledge catalyst

In the cath lab, ACIST gives you what you need to know.

Reducing contrast volume

For interventional cardiologists who want to manage contrast delivery and minimize risk of contrast-induced acute kidney injury (CI-AKI), ACIST CVi delivers the power to control and protect.

Optimizing interventions

ACIST HDi® provides you the power to see with clarity, for optimizing PCI through intravascular imaging. 

Complexity, simplified

ACIST RXi® and ACIST RXi® Mini simplify physiological assessment of complex coronary artery disease. The Navvus® 

MicroCatheters give you the freedom to quickly and easily assess FFR.

ACIST RXi® knowledge leadership

Pre- and Post-Physiological Assessment Using a Dedicated Monorail Microcatheter:
Dr. Arnold Seto

30+ million

Cases performed with CVi

3 views

Experience three imaging modes with HDi

0.014" guidewire

Use your guidewire of choice with RXi and the Navvus® MicroCatheters.

Investing in clinician education

ACIST provides a variety of clinical education materials, including clinical research, continuing education webinars, videos, instructional materials and more. 

Thinking ahead with our physician training

Help us determine what future physician training programs should be.

News

ACIST in the news.

Articles

Read our latest article.

Citations

  1. Westra J, Andersen BK et al; Diagnostic performance of in-procedure angiography-derive Quantitative Flow Reserve compared to pressure-derived Fractional Flow Reserve: The FAVOR II Europe-Japan Study J Am Heart Assoc 2018
  2. Data on file. TR-11392R. Based on an amplitude increase of 1.56mmHg and a significant p-value of 0.01 as compared to AT P65.
* economic value based on the reduced cost of QFR compared to conventional FFR and the respective cost of administration of hyperemic agent (adenosine) and additional invasive procedural resources ** Reduced side effect profile when compared to FFR with adenosine induced hyperemia

GENERAL CONDITIONS OF SALE